Log in to save to my catalogue

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical ca...

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5649573

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer

About this item

Full title

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer

Publisher

Greece: Spandidos Publications UK Ltd

Journal title

Oncology letters, 2017-10, Vol.14 (4), p.4467-4476

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications UK Ltd

More information

Scope and Contents

Contents

High-risk human papilloma virus (HPV) is the leading cause of cervical cancer. HPV oncogenes are responsible for the development of malignancy, and the E6 oncoprotein that HPV expresses induces the degradation of tumour suppressor protein p53 (p53). This degradation leads to the upregulation of p16; however, unidentified proteins may also serve a r...

Alternative Titles

Full title

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5649573

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5649573

Other Identifiers

ISSN

1792-1074

E-ISSN

1792-1082

DOI

10.3892/ol.2017.6752

How to access this item